| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2023―Mar―14 |
SARS-CoV-2 and male infertility: from short- to long-term impacts |
P. Dai, F. Qiao, Y. Chen, D. Y. L. Chan, H. C. H. Yim, K. L. Fok, H. Chen |
| 2 |
[GO] |
2023―Jan―28 |
Epidemiology, course, and outcomes of Sars-CoV-2 infection in patients with acromegaly and Cushing’s disease: a monocentric experience in Southern Italy |
M. Ragonese, G. Giuffrida, Y. Alessi, A. Giandalia, S. Giovinazzo, O. R. Cotta, et al. (+4) R. Certo, R. Casablanca, F. Ferraé, S. Cannavò |
| 3 |
[GO] |
2022―Nov―12 |
Serum testosterone mirrors inflammation parameters in females hospitalized with COVID-19 |
M. F. Birtolo, W. Vena, A. Pizzocaro, E. Lavezzi, A. Brunetti, S. Jaafar, et al. (+4) N. Betella, A. C. Bossi, G. Mazziotti, A. G. Lania |
| 4 |
[GO] |
2022―Nov―01 |
Insulin may increase disease severity and mortality of COVID-19 through Na+/H+ exchanger in patients with type 1 and type 2 diabetes mellitus |
E. Cure, M. Cumhur Cure |
| 5 |
[GO] |
2022―Oct―28 |
Prevalence and risk factors of erectile dysfunction in COVID-19 patients: a systematic review and meta-analysis |
J. Zhang, W. Shi, M. Zou, Q. Zeng, Y. Feng, Z. Luo, H. Gan |
| 6 |
[GO] |
2022―Oct―25 |
Relationship between hyponatremia at hospital admission and cardiopulmonary profile at follow-up in patients with SARS-CoV-2 (COVID-19) infection |
D. Malandrino, A. Berni, B. Fibbi, B. Borellini, D. Cozzi, D. Norello, et al. (+31) F. Fattirolli, F. Lavorini, I. Olivotto, C. Fumagalli, C. Zocchi, L. Tassetti, L. Gozzi, N. Marchionni, M. Maggi, A. Peri, Michele Spinicci, Lorenzo Zammarchi, Leonardo Gori, Guja Bernacchi, Lorenzo Ciambellotti, Iacopo Vellere, Matteo Vannini, Sara Montali, Francesco Tonarelli, Viola Camartini, Giada Turrin, Giuseppe Dario Testa, Simona Virciglio, Enrico Gardellini, Carolina Corsi, Sofia Espinoza Tofalos, Rossella Marcucci, Laura Rasero, Lorenzo Giovannoni, Luca Livi, Maria Vittoria Silverii |
| 7 |
[GO] |
2022―Sep―21 |
Shared genetic architecture between type 2 diabetes and COVID-19 severity |
J. Ni, L.-J. Qiu, K.-J. Yin, G.-M. Chen, H.-F. Pan |
| 8 |
[GO] |
2022―Sep―07 |
Electrolyte imbalances as poor prognostic markers in COVID-19: a systemic review and meta-analysis |
H. J. J. M. D. Song, A. Z. Q. Chia, B. K. J. Tan, C. B. Teo, V. Lim, H. R. Chua, et al. (+2) M. Samuel, A. Kee |
| 9 |
[GO] |
2022―Sep―05 |
Thyroid hormones and platelet activation in COVID-19 patients |
E. Colonnello, A. Criniti, E. Lorusso, M. Curreli, M. Santulli, A. Angeloni, et al. (+3) L. Gnessi, O. Gandini, C. Lubrano |
| 10 |
[GO] |
2022―Aug―09 |
Male reproductive health after 3 months from SARS-CoV-2 infection: a multicentric study |
D. Paoli, F. Pallotti, A. Anzuini, S. Bianchini, L. Caponecchia, A. Carraro, et al. (+15) M. R. Ciardi, F. Faja, C. Fiori, D. Gianfrilli, A. Lenzi, M. Lichtner, I. Marcucci, C. M. Mastroianni, G. Nigro, P. Pasculli, C. Pozza, F. Rizzo, P. Salacone, A. Sebastianelli, F. Lombardo |
| 11 |
[GO] |
2022―Jul―13 |
SARS-CoV-2 vaccine may trigger thyroid autoimmunity: real-life experience and review of the literature |
R. M. Ruggeri, L. Giovanellla, A. Campennì |
| 12 |
[GO] |
2022―Jul―13 |
Development of a prediction score (ThyroCOVID) for identifying abnormal thyroid function in COVID-19 patients |
D. T. W. Lui, C. H. Lee, W. S. Chow, A. C. H. Lee, A. R. Tam, C. Y. Y. Cheung, et al. (+9) C. H. Y. Fong, S. T. M. Kwok, C. Y. Law, K. K. W. To, C. W. Lam, K. C. B. Tan, Y. C. Woo, I. F. N. Hung, K. S. L. Lam |
| 13 |
[GO] |
2022―Jul―05 |
Subacute thyroiditis after SARS-CoV2 vaccine: possible relapse after boosting |
C. Teti, E. Nazzari, G. Graziani, M. Bagnasco |
| 14 |
[GO] |
2022―May―19 |
COVID-19 lockdown negatively impacted on adherence to denosumab therapy: incidence of non-traumatic fractures and role of telemedicine |
S. De Vincentis, D. Domenici, A. Ansaloni, G. Boselli, G. D’Angelo, A. Russo, et al. (+4) E. Taliani, V. Rochira, M. Simoni, B. Madeo |
| 15 |
[GO] |
2022―May―11 |
Is non-thyroidal illness syndrome (NTIS) a clinical predictor of COVID-19 mortality in critically ill oldest old patients? |
C. Okoye, F. Niccolai, S. Rogani, B. Lemmi, U. Peta, S. Del Vecchio, et al. (+4) V. Morelli, N. Caraccio, V. Calsolaro, F. Monzani |
| 16 |
[GO] |
2022―May―09 |
Andrological effects of SARS-Cov-2 infection: a systematic review and meta-analysis |
G. Corona, W. Vena, A. Pizzocaro, F. Pallotti, D. Paoli, G. Rastrelli, et al. (+13) E. Baldi, N. Cilloni, M. Gacci, F. Semeraro, A. Salonia, S. Minhas, R. Pivonello, A. Sforza, L. Vignozzi, A. M. Isidori, A. Lenzi, M. Maggi, F. Lombardo |
| 17 |
[GO] |
2022―Apr―06 |
Post-acute cardiac complications following SARS-CoV-2 infection in partial lipodystrophy due to LMNA gene p.R349W mutation |
G. Ceccarini, D. Gilio, S. Magno, C. Pelosini, M. Leverone, C. Miceli, et al. (+4) A. Barison, I. Fabiani, M. Emdin, F. Santini |
| 18 |
[GO] |
2022―Mar―29 |
COVID-19 vaccine and autoimmune diabetes in adults: report of two cases |
E. Bleve, V. Venditti, A. Lenzi, S. Morano, T. Filardi |
| 19 |
[GO] |
2022―Mar―29 |
Thyroid dysfunction following vaccination with COVID-19 vaccines: a basic review of the preliminary evidence |
A. Jafarzadeh, M. Nemati, S. Jafarzadeh, P. Nozari, S. M. J. Mortazavi |
| 20 |
[GO] |
2022―Mar―25 |
Health care access of thyroid disease patients in Serbia during the COVID-19 pandemic |
M. Žarković, P. Perros, J. Ćirić, B. Beleslin, M. Stojanović, M. Stojković, et al. (+2) M. Miletić, T. Janić |
| 21 |
[GO] |
2022―Feb―19 |
The potential impact of COVID-19 on male reproductive health |
T. T. Nguyen, J. Hulme, H. D. Tran, T. K. Vo, G. V. Vo |
| 22 |
[GO] |
2022―Feb―19 |
SARS-CoV-2 vaccıne-assocıated subacute thyroıdıtıs |
G. Yorulmaz, M. Sahin Tekin |
| 23 |
[GO] |
2022―Feb―15 |
Adipose tissue in COVID-19: detection of SARS-CoV-2 in adipocytes and activation of the interferon-alpha response |
A. Basolo, A. M. Poma, D. Bonuccelli, A. Proietti, E. Macerola, C. Ugolini, et al. (+6) L. Torregrossa, R. Giannini, P. Vignali, F. Basolo, F. Santini, A. Toniolo |
| 24 |
[GO] |
2022―Jan―29 |
SARS-CoV-2 vaccine-associated subacute thyroiditis: insights from a systematic review |
S. Ippolito, D. Gallo, A. Rossini, B. Patera, N. Lanzo, G. F. M. Fazzino, et al. (+2) E. Piantanida, M. L. Tanda |
| 25 |
[GO] |
2022―Jan―28 |
Response to Letter to the Editor from Lui et al.: ‘Euthyroid sick syndrome as an early surrogate marker of poor outcome in mild SARS-CoV-2 disease’: prognostic significance of non-thyroidal illness syndrome in the whole spectrum of COVID-19 severity |
C. Sparano, M. Maggi, L. Petrone |
| 26 |
[GO] |
2022―Jan―25 |
Safety issues in semen banks during the COVID-19 pandemic: data from a European survey |
S. Marchiani, S. Dabizzi, S. Degl’Innocenti, M. G. Fino, M. G. Torcia, D. Paoli, et al. (+7) F. Lombardo, N. Ciccone, S. Pollini, G. M. Rossolini, L. Vignozzi, C. Krausz, E. Baldi |
| 27 |
[GO] |
2022―Jan―22 |
Investigation of COVID-19 infection in subjects with Klinefelter syndrome |
L. Aliberti, I. Gagliardi, S. Lupo, M. Verrienti, M. Bondanelli, M. C. Zatelli, M. R. Ambrosio |
| 28 |
[GO] |
2022―Jan―16 |
Silent thyroiditis following vaccination against COVID-19: report of two cases |
M. Capezzone, M. Tosti-Balducci, E. M. Morabito, G. P. Caldarelli, A. Sagnella, S. Cantara, et al. (+2) M. Alessandri, M. G. Castagna |
| 29 |
[GO] |
2022―Jan―13 |
Subacute thyroiditis during the COVID-19 pandemic: a prospective study |
A. B. Bahçecioğlu, Z. C. Karahan, B. İ. Aydoğan, İ. A. Kalkan, A. Azap, M. F. Erdoğan |
| 30 |
[GO] |
2022―Jan―13 |
Letter to the Editor: ‘Euthyroid sick syndrome as an early surrogate marker of poor outcome in mild SARS-CoV-2 disease’-prognostic significance of non-thyroidal illness syndrome across the whole spectrum of COVID-19 severity |
David Tak Wai Lui, Chi Ho Lee, Karen Siu Ling Lam |
| 31 |
[GO] |
2022―Jan―11 |
Thyrotoxicosis following SARS-COV-2 vaccination: a case series and discussion |
B. Pla Peris, A. Á. Merchante Alfaro, F. J. Maravall Royo, P. Abellán Galiana, S. Pérez Naranjo, M. González Boillos |
| 32 |
[GO] |
2022―Jan―05 |
SARS-CoV-2 detection in primary thyroid sarcoma: coincidence or interaction? |
M. L. Tanda, S. Ippolito, D. Gallo, A. Baj, F. Novazzi, A. Genoni, et al. (+10) M. Annoni, N. Mancini, N. Clementi, G. Finzi, E. Piantanida, P. Premoli, A. Lai, D. Dalla Gasperina, F. Maggi, S. Uccella |
| 33 |
[GO] |
2021―Dec―01 |
Euthyroid sick syndrome as an early surrogate marker of poor outcome in mild SARS-CoV-2 disease |
C. Sparano, E. Zago, A. Morettini, C. Nozzoli, D. Yannas, V. Adornato, et al. (+4) E. Caldini, M. Vaudo, M. Maggi, L. Petrone |
| 34 |
[GO] |
2021―Nov―30 |
Increased odds ratio for erectile dysfunction in COVID-19 patients |
J. Katz, S. Yue, W. Xue, H. Gao |
| 35 |
[GO] |
2021―Nov―18 |
Low testosterone predicts hypoxemic respiratory insufficiency and mortality in patients with COVID-19 disease: another piece in the COVID puzzle |
W. Vena, A. Pizzocaro, G. Maida, M. Amer, A. Voza, A. Di Pasquale, et al. (+7) F. Reggiani, M. Ciccarelli, C. Fedeli, D. Santi, E. Lavezzi, A. G. Lania, G. Mazziotti |
| 36 |
[GO] |
2021―Nov―18 |
Thyroid as a target of adjuvant autoimmunity/inflammatory syndrome due to mRNA-based SARS-CoV2 vaccination: from Graves’ disease to silent thyroiditis |
A. Pujol, L.-A. Gómez, C. Gallegos, J. Nicolau, P. Sanchís, M. González-Freire, et al. (+3) Á. A. López-González, K. Dotres, L. Masmiquel |
| 37 |
[GO] |
2021―Nov―15 |
Quality of life and other patient-reported outcomes in adult Lebanese patients with type 2 diabetes during COVID-19 pandemic |
E. Naous, M. Boulos, G. Sleilaty, A. A. Achkar, M.-H. Gannagé-Yared |
| 38 |
[GO] |
2021―Nov―05 |
Higher testosterone is associated with increased inflammatory markers in women with SARS-CoV-2 pneumonia: preliminary results from an observational study |
V. Di Stasi, G. Rastrelli, F. Inglese, M. Beccaria, M. Garuti, D. Di Costanzo, et al. (+13) F. Spreafico, G. Cervi, G. F. Greco, A. Pecoriello, T. Todisco, S. Cipriani, E. Maseroli, I. Scavello, C. Glingani, M. Franchini, M. Maggi, G. De Donno, L. Vignozzi |
| 39 |
[GO] |
2021―Oct―20 |
Deciphering the link between Diabetes mellitus and SARS-CoV-2 infection through differential targeting of microRNAs in the human pancreas |
E. Pathak, R. Mishra |
| 40 |
[GO] |
2021―Oct―15 |
Glucose control in type 1 diabetes and COVID-19 |
R. Mungmunpuntipantip, V. Wiwanitkit |
| 41 |
[GO] |
2021―Sep―24 |
Social environmental impact of COVID-19 and erectile dysfunction: an explorative review |
D. Pizzol, J. I. Shin, M. Trott, P.-C. Ilie, S. Ippoliti, A. M. Carrie, et al. (+13) R. A. Ghayda, J. M. O. Lozano, J. M. Muyor, L. Butler, D. T. McDermott, Y. Barnett, L. Markovic, Igor Grabovac, A. Koyanagi, P. Soysal, M. A. Tully, N. Veronese, L. Smith |
| 42 |
[GO] |
2021―Sep―10 |
Letter to the editor: how the COVID-19 pandemic has changed outpatient diagnosis in the andrological setting |
R. Mazzilli, V. Zamponi, A. Faggiano |
| 43 |
[GO] |
2021―Sep―05 |
Glucose control in home-isolated adults with type 1 diabetes affected by COVID-19 using continuous glucose monitoring |
M. Longo, L. Scappaticcio, M. Petrizzo, F. Castaldo, A. Sarnataro, D. Forestiere, et al. (+5) F. Caiazzo, G. Bellastella, M. I. Maiorino, A. Capuano, K. Esposito |
| 44 |
[GO] |
2021―Sep―03 |
Mystery of love, goiter and death in flu pandemic |
J. Jaksic, V. Pandzic Jaksic |
| 45 |
[GO] |
2021―Aug―03 |
Two further cases of Graves’ disease following SARS-Cov-2 vaccination |
G. Zettinig, M. Krebs |
| 46 |
[GO] |
2021―Jul―26 |
Non-thyroidal illness syndrome and SARS-CoV-2-associated multisystem inflammatory syndrome in children |
V. Calcaterra, G. Biganzoli, D. Dilillo, S. Mannarino, L. Fiori, G. Pelizzo, et al. (+9) E. Zoia, V. Fabiano, P. Carlucci, A. Camporesi, C. Corti, G. Mercurio, F. Izzo, E. Biganzoli, G. Zuccotti |
| 47 |
[GO] |
2021―Jul―19 |
Thyroid surgery during the COVID-19 pandemic: results from a systematic review |
L. Scappaticcio, M. I. Maiorino, S. Iorio, C. Camponovo, A. Piccardo, G. Bellastella, et al. (+3) G. Docimo, K. Esposito, P. Trimboli |
| 48 |
[GO] |
2021―Jul―17 |
Vitamin D supplementation and COVID-19 risk: a population-based, cohort study |
J. Oristrell, J. C. Oliva, E. Casado, I. Subirana, D. Domínguez, A. Toloba, et al. (+2) A. Balado, M. Grau |
| 49 |
[GO] |
2021―Jul―03 |
Central diabetes insipidus (Infundibuloneuro hypophysitis): A late complication of COVID-19 infection |
R. A. Misgar, A. Rasool, A. I. Wani, M. I. Bashir |
| 50 |
[GO] |
2021―Jun―30 |
COVID-19 autopsy cases: detection of virus in endocrine tissues |
A. M. Poma, D. Bonuccelli, R. Giannini, E. Macerola, P. Vignali, C. Ugolini, et al. (+7) L. Torregrossa, A. Proietti, M. Pistello, A. Basolo, F. Santini, A. Toniolo, F. Basolo |
| 51 |
[GO] |
2021―Jun―30 |
Risks of potential drug-drug interactions in COVID-19 patients treated with corticosteroids: a single-center experience |
D. Cattaneo, L. Pasina, F. Conti, A. Giacomelli, L. Oreni, L. Pezzati, et al. (+5) C. Bonazzetti, M. Piscaglia, G. Carrozzo, S. Antinori, C. Gervasoni |
| 52 |
[GO] |
2021―Jun―24 |
Vitamin D supplementation and clinical outcomes in COVID-19: a systematic review and meta-analysis |
R. Pal, M. Banerjee, S. K. Bhadada, A. J. Shetty, B. Singh, A. Vyas |
| 53 |
[GO] |
2021―Jun―08 |
Thyroid dysfunction in COVID-19 patients |
R. Baldelli, E. Nicastri, N. Petrosillo, L. Marchioni, A. Gubbiotti, I. Sperduti, et al. (+8) P. Di Giacinto, L. Rizza, F. Rota, M. Franco, A. Lania, G. Aimaretti, G. Ippolito, P. Zuppi |
| 54 |
[GO] |
2021―May―26 |
Metabolic syndrome in the era of COVID-19 outbreak: impact of lockdown on cardiometabolic health |
R. S. Auriemma, R. Pirchio, A. Liccardi, R. Scairati, G. Del Vecchio, R. Pivonello, A. Colao |
| 55 |
[GO] |
2021―May―08 |
Graves’ disease and Graves’ orbitopathy following COVID-19 |
G. Lanzolla, C. Marcocci, M. Marinò |
| 56 |
[GO] |
2021―Apr―30 |
Molecular diagnosis of SARS-CoV-2 in seminal fluid |
D. Paoli, F. Pallotti, G. Nigro, L. Mazzuti, M. N. Hirsch, M. B. Valli, et al. (+6) S. Colangelo, C. M. Mastroianni, G. Antonelli, A. Lenzi, O. Turriziani, F. Lombardo |
| 57 |
[GO] |
2021―Apr―17 |
Secondary prevention of fragility fractures: where do we stand during the COVID-19 pandemic? |
A. Falchetti, M. Mohseni, F. Tramontana, N. Napoli |
| 58 |
[GO] |
2021―Apr―11 |
Vitamin D and Vitamin D binding protein: the inseparable duo in COVID-19 |
M. M. Speeckaert, R. Speeckaert, J. R. Delanghe |
| 59 |
[GO] |
2021―Apr―05 |
Retrospective analysis of vitamin D status on ınflammatory markers and course of the disease in patients with COVID-19 infection |
Y. A. Ünsal, Ö. Ö. Gül, S. Cander, C. Ersoy, E. Aydemir, C. Ateş, et al. (+4) Z. Uzun, E. Armağan, O. Ünsal, E. Ertürk |
| 60 |
[GO] |
2021―Mar―25 |
Thyroid and COVID-19: a review on pathophysiological, clinical and organizational aspects |
G. Lisco, A. De Tullio, E. Jirillo, V. A. Giagulli, G. De Pergola, E. Guastamacchia, V. Triggiani |
| 61 |
[GO] |
2021―Mar―05 |
Vitamin D deficiency, secondary hyperparathyroidism and respiratory insufficiency in hospitalized patients with COVID-19 |
G. Mazziotti, E. Lavezzi, A. Brunetti, M. Mirani, G. Favacchio, A. Pizzocaro, et al. (+5) M. T. Sandri, A. Di Pasquale, A. Voza, M. Ciccarelli, A. G. Lania |
| 62 |
[GO] |
2021―Feb―28 |
Osteoporosis care amidst the prolonged pandemic |
R. R. Narla, R. A. Adler |
| 63 |
[GO] |
2021―Feb―14 |
Relationship between betacoronaviruses and the endocrine system: a new key to understand the COVID-19 pandemic-A comprehensive review |
T. Piticchio, R. Le Moli, D. Tumino, F. Frasca |
| 64 |
[GO] |
2021―Feb―10 |
The cytokine storm and thyroid hormone changes in COVID-19 |
L. Croce, D. Gangemi, G. Ancona, F. Liboà, G. Bendotti, L. Minelli, L. Chiovato |
| 65 |
[GO] |
2021―Jan―29 |
Anosmia and ageusia: a piece of the puzzle in the etiology of COVID-19-related transitory erectile dysfunction |
R. Bertolo, C. Cipriani, P. Bove |
| 66 |
[GO] |
2021―Jan―29 |
Disentangling conflicting evidence on DPP-4 inhibitors and outcomes of COVID-19: narrative review and meta-analysis |
B. M. Bonora, A. Avogaro, G. P. Fadini |
| 67 |
[GO] |
2021―Jan―04 |
Why diabetes outpatient clinics should not close during pandemic crises |
G. P. Fadini, B. M. Bonora, M. L. Morieri, A. Avogaro |
| 68 |
[GO] |
2020―Dec―23 |
Tele-medicine versus face-to-face consultation in Endocrine Outpatients Clinic during COVID-19 outbreak: a single-center experience during the lockdown period |
F. Ceccato, G. Voltan, C. Sabbadin, V. Camozzi, I. Merante Boschin, C. Mian, et al. (+6) V. Zanotto, D. Donato, G. Bordignon, A. Capizzi, G. Carretta, C. Scaroni |
| 69 |
[GO] |
2020―Nov―02 |
Thyroid hormone concentrations in severely or critically ill patients with COVID-19 |
W. Gao, W. Guo, Y. Guo, M. Shi, G. Dong, G. Wang, et al. (+3) Q. Ge, J. Zhu, X. Zhou |
| 70 |
[GO] |
2020―Oct―10 |
Sperm cryopreservation during the SARS-CoV-2 pandemic |
D. Paoli, F. Pallotti, G. Nigro, A. Aureli, A. Perlorca, L. Mazzuti, et al. (+4) D. Di Carlo, O. Turriziani, A. Lenzi, F. Lombardo |
| 71 |
[GO] |
2020―Oct―07 |
Detection of SARS-COV-2 receptor ACE-2 mRNA in thyroid cells: a clue for COVID-19-related subacute thyroiditis |
M. Rotondi, F. Coperchini, G. Ricci, M. Denegri, L. Croce, S. T. Ngnitejeu, et al. (+4) L. Villani, F. Magri, F. Latrofa, L. Chiovato |
| 72 |
[GO] |
2020―Oct―07 |
COVID-19: a cause of recurrent Graves’ hyperthyroidism? |
S. Jiménez-Blanco, B. Pla-Peris, M. Marazuela |
| 73 |
[GO] |
2020―Sep―18 |
Impact of COVID-19 pandemic on psychophysical stress in patients with adrenal insufficiency: the CORTI-COVID study |
M. Martino, N. Aboud, M. F. Cola, G. Giancola, A. Ciarloni, G. Salvio, G. Arnaldi |
| 74 |
[GO] |
2020―Sep―16 |
Gender susceptibility to COVID-19: a review of the putative role of sex hormones and X chromosome |
C. Foresta, M. S. Rocca, A. Di Nisio |
| 75 |
[GO] |
2020―Sep―11 |
COVID-19 in Cushing disease: experience of a single tertiary centre in Lombardy |
A. L. Serban, E. Ferrante, G. Carosi, R. Indirli, M. Arosio, G. Mantovani |
| 76 |
[GO] |
2020―Sep―03 |
The immune-modulatory effects of exercise should be favorably harnessed against COVID-19 |
R. Codella, A. Chirico, F. Lucidi, A. Ferrulli, A. La Torre, L. Luzi |
| 77 |
[GO] |
2020―Sep―02 |
Thyroid surgery during coronavirus-19 pandemic phases I, II and III: lessons learned in China, South Korea, Iran and Italy |
D. Zhang, Y. Fu, L. Zhou, N. Liang, T. Wang, P. Del Rio, et al. (+9) S. Rausei, L. Boni, D. Park, J. Jafari, S. Kargar, H. Y. Kim, M. L. Tanda, G. Dionigi, H. Sun |
| 78 |
[GO] |
2020―Aug―29 |
Controlled obesity status: a rarely used concept, but with particular importance in the COVID-19 pandemic and beyond |
B. Halpern, M. C. Mancini |
| 79 |
[GO] |
2020―Aug―28 |
What we have to know about corticosteroids use during Sars-Cov-2 infection |
F. Ferraé, F. Ceccato, S. Cannavò, C. Scaroni |
| 80 |
[GO] |
2020―Aug―27 |
High body mass index and night shift work are associated with COVID-19 in health care workers |
S. Rizza, L. Coppeta, S. Grelli, G. Ferrazza, M. Chiocchi, G. Vanni, et al. (+5) O. C. Bonomo, A. Bellia, M. Andreoni, A. Magrini, M. Federici |
| 81 |
[GO] |
2020―Aug―16 |
Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet) |
F. Panzuto, M. Maccauro, D. Campana, A. Faggiano, S. Massironi, S. Pusceddu, et al. (+21) F. Spada, D. Ferone, R. Modica, C. M. Grana, P. Ferolla, M. Rinzivillo, G. Badalamenti, M. C. Zatelli, F. Gelsomino, E. De Carlo, M. Bartolomei, M. P. Brizzi, S. Cingarlini, A. Versari, G. Fanciulli, E. Arvat, E. Merola, M. Cives, S. Tafuto, S. Baldari, M. Falconi |
| 82 |
[GO] |
2020―Aug―10 |
Impact of diabetes on COVID-19-related in-hospital mortality: a retrospective study from Northern Italy |
S. Ciardullo, F. Zerbini, S. Perra, E. Muraca, R. Cannistraci, M. Lauriola, et al. (+6) P. Grosso, G. Lattuada, G. Ippoliti, A. Mortara, G. Manzoni, G. Perseghin |
| 83 |
[GO] |
2020―Aug―09 |
Vitamin D deficiency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID-19 |
G. E. Carpagnano, V. Di Lecce, V. N. Quaranta, A. Zito, E. Buonamico, E. Capozza, et al. (+4) A. Palumbo, G. Di Gioia, V. N. Valerio, O. Resta |
| 84 |
[GO] |
2020―Jul―19 |
The informative experience of endocrine residents with COVID-19 |
M. Di Stefano, S. Federici, L. Giovanelli, B. Nadiani, F. Nicoli, M. Trevisan |
| 85 |
[GO] |
2020―Jul―19 |
SARS-COV-2 as a trigger for autoimmune disease: report of two cases of Graves’ disease after COVID-19 |
M. Mateu-Salat, E. Urgell, A. Chico |
| 86 |
[GO] |
2020―Jul―13 |
Addressing male sexual and reproductive health in the wake of COVID-19 outbreak |
A. Sansone, D. Mollaioli, G. Ciocca, E. Limoncin, E. Colonnello, W. Vena, E. A. Jannini |
| 87 |
[GO] |
2020―Jul―10 |
Pituitary surgery during Covid-19: a first hand experience and evaluation |
F. Penner, S. Grottoli, M. M. R. Lanotte, D. Garbossa, F. Zenga |
| 88 |
[GO] |
2020―Jun―17 |
Possible role of vitamin D in Covid-19 infection in pediatric population |
F. M. Panfili, M. Roversi, P. D’Argenio, P. Rossi, M. Cappa, D. Fintini |
| 89 |
[GO] |
2020―Jun―09 |
A COVID-19 pneumonia case report of autoimmune polyendocrine syndrome type 1 in Lombardy, Italy: letter to the editor |
G. Beccuti, L. Ghizzoni, V. Cambria, V. Codullo, P. Sacchi, E. Lovati, et al. (+3) S. Mongodi, G. A. Iotti, F. Mojoli |
| 90 |
[GO] |
2020―Jun―08 |
Systemic steroids in patients with COVID-19: pros and contras, an endocrinological point of view |
A. M. Berton, N. Prencipe, R. Giordano, E. Ghigo, S. Grottoli |
| 91 |
[GO] |
2020―Jun―05 |
A case of subacute thyroiditis associated with Covid-19 infection |
E. Asfuroglu Kalkan, I. Ates |
| 92 |
[GO] |
2020―Jun―03 |
COVID-19: is there a link between the course of infection and pharmacological agents in diabetes? |
T. Filardi, S. Morano |
| 93 |
[GO] |
2020―Jun―02 |
Endocrine complications of COVID-19: what happens to the thyroid and adrenal glands? |
G. Bellastella, M. I. Maiorino, K. Esposito |
| 94 |
[GO] |
2020―Jun―02 |
SARS-CoV-2: a potential trigger for subacute thyroiditis? Insights from a case report |
S. Ippolito, F. Dentali, M. L. Tanda |
| 95 |
[GO] |
2020―May―28 |
COVID-19 may affect the endocrine pancreas by activating Na+/H+ exchanger 2 and increasing lactate levels |
E. Cure, M. Cumhur Cure |
| 96 |
[GO] |
2020―May―27 |
SARS-CoV-2 infection, male fertility and sperm cryopreservation: a position statement of the Italian Society of Andrology and Sexual Medicine (SIAMS) (Società Italiana di Andrologia e Medicina della Sessualità) |
G. Corona, E. Baldi, A. M. Isidori, D. Paoli, F. Pallotti, L. De Santis, et al. (+11) F. Francavilla, S. La Vignera, R. Selice, L. Caponecchia, R. Pivonello, A. Ferlin, C. Foresta, E. A. Jannini, A. Lenzi, M. Maggi, F. Lombardo |
| 97 |
[GO] |
2020―May―25 |
Hyponatremia, IL-6, and SARS-CoV-2 (COVID-19) infection: may all fit together? |
A. Berni, D. Malandrino, G. Parenti, M. Maggi, L. Poggesi, A. Peri |
| 98 |
[GO] |
2020―May―21 |
Management of Graves’ hyperthyroidism and orbitopathy in time of COVID-19 pandemic |
L. Bartalena, L. Chiovato, C. Marcocci, P. Vitti, E. Piantanida, M. L. Tanda |
| 99 |
[GO] |
2020―May―02 |
COVID-19 and the endocrine system: exploring the unexplored |
R. Pal, M. Banerjee |
| 100 |
[GO] |
2020―Apr―25 |
COVID-19 infection and glucocorticoids: update from the Italian Society of Endocrinology Expert Opinion on steroid replacement in adrenal insufficiency |
A. M. Isidori, G. Arnaldi, M. Boscaro, A. Falorni, C. Giordano, R. Giordano, et al. (+8) R. Pivonello, R. Pofi, V. Hasenmajer, M. A. Venneri, E. Sbardella, C. Simeoli, C. Scaroni, A. Lenzi |
| 101 |
[GO] |
2020―Apr―23 |
Study of SARS-CoV-2 in semen and urine samples of a volunteer with positive naso-pharyngeal swab |
D. Paoli, F. Pallotti, S. Colangelo, F. Basilico, L. Mazzuti, O. Turriziani, et al. (+3) G. Antonelli, A. Lenzi, F. Lombardo |
| 102 |
[GO] |
2020―Apr―16 |
COVID-19 outbreak and steroids administration: are patients treated for Sars-Cov-2 at risk of adrenal insufficiency? |
C. Scaroni, M. Armigliato, S. Cannavò |
| 103 |
[GO] |
2020―Mar―28 |
Prevalence and impact of diabetes among people infected with SARS-CoV-2 |
G. P. Fadini, M. L. Morieri, E. Longato, A. Avogaro |
|
